Bills: HR290, HR298, SB405, SCR61, HR318

Keywords: gender-affirming care, gender affirming therapy, gender-affirming hormone therapy, transgender health, trans youth, LGBTQ, mental health, psychosis, psychiatric conditions, puberty blockers, androgen blockers, cross-sex hormones, estrogen, testosterone, informed consent, screening, monitoring protocols, Louisiana Department of Health, LDH, House Health and Welfare

Transcript Highlights:

• I am thankful to have had access to both fertility services and medications, including estrogen.
• In January 2023, prior to my next IVF transfer, I started twice-a-week intramuscular estrogen shots,
• along with daily shots, as well as a combined progesterone and estrogen daily medication.
• In January 2023, prior to my next IVF transfer, I started twice a week intramuscular estrogen shots,
• along with daily shots, as well as a combined progesterone and estrogen daily medication.

Summary: The committee heard several health-related bills, with extensive testimony on maternal health, prenatal safety, privacy, valley fever, Medi-Cal contracting, anti-discrimination protections, and health data sharing. SB 32 would require time-and-distance standards for labor and delivery units in health plan networks; the author and supporters said it would address maternity care deserts and improve access, while health plans opposed. SB 646 would require testing and public disclosure for toxic elements in prenatal vitamins; supporters emphasized fetal and maternal safety and transparency, while industry opponents warned it could confuse consumers or lead to reduced nutrient content. Both bills drew broad support from medical and public health groups, and both were advanced on party-line or near-unanimous votes after committee discussion. The committee also approved SB 313, which moves a parent’s birthplace on birth certificates into the confidential section to protect privacy, and SB 297, which directs CDPH to identify high-incidence valley fever regions and publish them for screening and awareness; valley fever experts and supporters stressed rising cases and the need for earlier diagnosis, while local health jurisdictions raised concerns about mandates. SB 324, dealing with Medi-Cal enhanced care management and community supports, would prioritize local community-based organizations and clarify contracting and data practices; it received strong support from nonprofits and community health advocates, with children’s hospitals and health plans seeking amendments, and it was sent forward after amendments were discussed. The committee then considered SB 418, which would codify ACA nondiscrimination protections in state law and allow up to a 12-month prescription supply for hormone therapy when medically necessary. Supporters framed it as protecting continuity of care for transgender patients and others using hormone therapy, including IVF and menopause patients, while opponents argued it would conflict with federal policy and promote harmful treatments. The bill passed to the next committee. Finally, SB 660 would strengthen the California Health and Human Services data exchange framework by creating governance and accountability for data sharing across health and social service entities; supporters said it would reduce duplication and improve care coordination, while some providers and hospital groups raised concerns. It was approved and sent to the Privacy and Consumer Protection Committee. The consent calendar and the other measures were also voted out, with the committee recording the required roll-call votes and sending the bills onward.

Transcript Highlights:

• When every menopausal woman got estrogen and they found out the problems, now zero women get estrogen
• and they found out got estrogen and they found out the<00:09:29.760> problems<00:09:30.240>
• Estrogen alone is not prescribed in a woman who has a uterus; estrogen is combined with progesterone
• to prevent the type of concerns that estrogen therapy by itself can create.
• <00:11:04.880> is<00:11:05.120> combined who has a uterus estrogen is combined who

Keywords: 1189, house, all

Transcript Highlights:

• She explained that transdermal estrogen was safe.
• After a discussion with my doctor, he agreed to give me low-dose estrogen.
• After a discussion with my doctor, he agreed to give me low-dose estrogen.
• We know that low-estrogen states cause...
• on medications that will stop the ovaries from producing estrogen.

Keywords: 995, all

Summary: The committee opened by explaining hearing procedures and time limits, then heard testimony on House 2499, a bill to create a public awareness campaign on menopause and related midlife health issues. Supporters, including a nurse, the Massachusetts Commission on the Status of Women, and other advocates, said menopause is widely misunderstood by patients and providers, leading to delayed care, unnecessary suffering, workplace impacts, and inequities in women’s health. Several speakers shared personal experiences with symptoms being dismissed or misdiagnosed and urged the committee to advance the bill. The committee then took testimony on a package of endometriosis bills, including House 2527 and Senate 1564, calling for a task force and broader awareness efforts. Patients, a physician, and advocates described long diagnostic delays, severe pain, infertility, medical gaslighting, and limited access to specialists and effective treatment. They argued for more research, provider education, and a coordinated state strategy, and several asked for favorable reports. The chair also noted the hearing was running behind and extended time to allow more testimony. Later, the committee heard Senate 1579, which would eliminate parental consent and judicial bypass requirements for abortion access for minors under 16. Planned Parenthood representatives, physicians, legal advocates, and students argued the current law creates unnecessary delays and harms vulnerable youth, especially those in unsafe homes or foster care, while supporters said minors can already consent to other reproductive health care. A pro-life witness opposed the bill and emphasized parental involvement and support services. The committee also heard House 2403 and Senate 1560, which would create a Human Service Transportation Consumer Advisory Board; disability advocates and riders described past safety problems and current service gaps, and supported the board as a low-cost way to improve accountability, rider input, and reliability. No votes or final actions were taken in the excerpt.

Transcript Highlights:

• I could technically take estrogen, but it would be very uncomfortable for me.
• He could technically take estrogen, but it would be very uncomfortable for him.
• gone through an estrogen field field uh<02:29:38.760> puberty<02:29:39.279> long<02:29
• They said I could either start on estrogen or spironolactone, but I could only start one at a time to
• <02:56:21.399> and much needed to start estrogen and much needed to start estrogen and spirolactone

Keywords: 1189, house, all

Transcript Highlights:

• anyway, I went in and I said, oh, I don't want to keep my ovaries so that it can continue to generate estrogen
• So I don't need to be on estrogen therapy.

Bills: SM14

Keywords: forced sterilization, coerced sterilization, Indigenous women, Native American women, women of color, reproductive justice, reproductive sovereignty, truth and reconciliation commission, memorial, trauma-informed care, reparative justice, human rights, bodily autonomy, Indian Health Service, Indian affairs, Commission on the Status of Women, survivor testimony, reproductive health access, genocide, transitional justice

Transcript Highlights:

• To be clear, I'm still a woman even though my body's not making estrogen right now.
• To be clear, I'm still a woman even though my body's not making estrogen right now.
• To be clear, I'm still a woman even though my body's not making estrogen right now.
• To be clear, I'm still a woman even though my body's not making estrogen right now.
• I'm still a woman even though my body's not making estrogen right now.

Keywords: 928, house, all

Summary: The House Committee on Health, Human Services and Elderly Affairs heard testimony on House Bill 606, as amended, a bill aimed at preventing physicians from denying medically necessary sterilizing or fertility-affecting treatment based on a patient’s age, number of children, marital status, or a doctor’s speculation about future reproductive intentions. Representative Ellen Reed, the sponsor, described the bill as a response to her own long experience with PCOS, heavy bleeding, and repeated refusals by doctors to perform a hysterectomy despite her clear wishes. She said the amendment narrows the bill to medically necessary care, adds definitions for “medical condition” and “appropriate reproductive care,” and removes earlier provisions about voluntary sterilization referrals. She also said the bill does not target religious objections, and that doctors could still refuse for medical, payment, or existing religious reasons not addressed by the bill. Committee members asked about religious freedom, informed consent versus waivers, and the scope of the new definitions. Reed responded that religion was not added to the list of prohibited reasons for denial, and that the amendment is intended to protect doctors when patients sign informed consent or waivers. She explained that “appropriate reproductive care” includes procedures such as hysterectomy, oophorectomy, orchiectomy, salpingectomy, and endometrial ablation, and that the bill now focuses on medically necessary treatment rather than elective sterilization. She said the change was intended to make the proposal narrower and more tailored after earlier concerns. Several witnesses supported the bill with personal accounts of being denied hysterectomies or other procedures despite serious symptoms. Representative Lauren Selig described a decade-long effort to obtain a hysterectomy after years of cycle problems and migraines, saying doctors dismissed her concerns and treated her symptoms as normal. Jade Flad also testified in support, saying she had long been told to simply endure her cycle problems and noted that her husband was offered a vasectomy without similar barriers. The sponsor said online support was strong and that there was little or no written opposition testimony. No vote or final committee action was taken during the portion of the hearing provided.

Transcript Highlights:

• I know more about my biology than you do, and my biology is that of someone with an estrogen hormone
• But if it's someone who is assigned male at birth, but has been on estrogen for 25, 30 years, their profile
• And so, again, if we had someone who'd been on estrogen for 20 or 30 years, their profile should be looked
• Could you tell me the primary reason for estrogen was first studied in an assigned male at birth individual

Bills: HB 45, HB 755, HB 1232, HB 1555, HB 2460, HB 2702, HB 2973, HB 3120, HB 3225, HB 3314, HB 3356, HB 3371, HB 3634, HB 3638, HB 4247, HB 4283, HB 4290, HB 4302, HB 4503, HB 4511, HB 4565, HB 4581, HB 4627, HB 4632, HB 4660, HB 4668, HB 4960, HB 5042

Keywords: housing, affordable housing, rent control, landlord-tenant laws, housing rights, lobbying, public entities, expenditures, government code, transparency, Texas Ethics Commission, government regulation, lobbying restrictions, government accountability, taxpayer money, HB 1232, whistleblower, whistleblower protection, public employee, retaliation

Transcript Highlights:

• I know more about my biology than you do, and my biology is that of someone with an estrogen hormone
• But if it's someone who was assigned male at birth but has been on estrogen for 20, 30 years, their profile
• So again, if we had someone who'd been on estrogen for 20 or 30 years, their profile should be looked
• Could you tell me the primary reason for estrogen was first studied in an assigned male at birth individual

Bills: HB45, HB45, HB755, HB 1232, HB1555, HB2460, HB2702, HB2973, HB3120, HB3225, HB3314, HB3356, HB3371, HB3634, HB3638, HB4247, HB4283, HB4290, HB4302, HB4503, HB4511, HB4565, HB4581, HB4627, HB4632, HB4660, HB4668, HB4960, HB5042

Keywords: flooding, disaster response, emergency preparedness, state guidance, public safety, housing, affordable housing, rent control, landlord-tenant laws, housing rights, lobbying, public entities, expenditures, government code, transparency, Texas Ethics Commission, government regulation, lobbying restrictions, government accountability, taxpayer money

Transcript Highlights:

• were studying gender identity, you know, 100 years ago and started treating patients as soon as estrogen
• that... ...some eight-year-old who comes to the clinic is going to be started on testosterone or estrogen
• testosterone blockers at that point, not literally puberty blockers, and eventually transitioned to estrogen
• , synthetic estrogen, which has helped her to feel more like the person that she knows herself to be
• Not for a moment, because I don't want to get too graphic, but every change that the estrogen created

Keywords: 959, house, all

Transcript Highlights:

• And I was advised by another person that to keep my ovaries because that would keep the estrogen production
• And I wouldn't need to get on estrogen therapy. So I told that to the surgeon and medical team.

Bills: SM13, SM14

Keywords: land grant, Las Vegas, governance, self-governance, judicial management, forced sterilization, coerced sterilization, Indigenous women, Native American women, women of color, reproductive justice, reproductive sovereignty, truth and reconciliation commission, memorial, trauma-informed care, reparative justice, human rights, bodily autonomy, Indian Health Service, Indian affairs

Transcript Highlights:

• I had one doctor tell me, oh, well, when your body stops producing estrogen, you stop being a woman.
• Um, to be clear, I'm still a woman even though my body's not making estrogen right now.
• when your body stops producing estrogen when your body stops producing estrogen you<00:29:00.200
• body's I'm still a woman even though my body's not<00:29:06.880> making<00:29:07.120> estrogen
• right now um but so not making estrogen right now um but so I<00:29:10.039> support<00:29:10.399

Keywords: 1189, house, all

Transcript Highlights:

• Some of these chemicals are structurally similar to estrogen and therefore recognized by the body as
• estrogen.
• This fools the body into thinking puberty-related hormones are being released, and this estrogenic effect

Keywords: 995, all

Summary: The hearing of the Joint Committee on Consumer Protection and Professional Licensure opened with logistical remarks about testimony procedures, time limits, accessibility supports, and the large number of witnesses. The first bill discussed was H. 451, which would allow professional license applicants who do not have a Social Security number to use an ITIN instead. Supporters said the bill would help qualified workers, especially immigrants, enter licensed trades and professions without lowering training or testing standards, while addressing workforce shortages. Committee members asked a few questions, and the bill was framed as a uniform statewide licensing reform. The bulk of the hearing focused on S. 210 and H. 1278, two bills aimed at improving wheelchair repair and warranty protections. Supporters included the Attorney General’s Office, disability advocates, wheelchair users, clinicians, and legislators, who described long repair delays, missed work and medical appointments, loss of independence, hospitalizations, pressure injuries, and other harms caused by broken wheelchairs and slow service. They argued for stronger timelines, two-year warranties, required parts availability, loaner chairs, and enforcement mechanisms, with H. 1278 modeled on a Connecticut-style repair deadline and S. 210 focused on warranty protections. Several witnesses emphasized that wheelchairs are essential medical equipment, not ordinary consumer goods. Opposition came from NCart, which said it supports solutions but raised concerns that the bills, as written, could be difficult to implement for complex rehab technology. NCart said some warranty provisions may not fit wear-and-tear components and noted that MassHealth has already taken steps such as preventive maintenance, reduced prior authorization, and transportation support. Other witnesses and advocates countered that the current market is dominated by a few profitable companies and that the legislature needs to impose clear standards because voluntary fixes have not worked. The committee also heard testimony on S. 195, a toxic-free kids bill from Senator Comerford and Representative Hawkins, which would restrict PFAS and other toxic chemicals in children’s products and create disclosure and phase-out requirements. No votes were taken during the hearing.

Transcript Highlights:

• Cross hormones, such as testosterone and estrogen, are not allowed to begin until the child has met the
• Cross hormones, such as testosterone and estrogen, are not allowed to begin until the child has met the
• Cross hormones, such as testosterone and estrogen, are not allowed to begin until the child has met the
• Cross hormones, such as testosterone and estrogen, are not allowed to begin until the child has met the
• Cross hormones, such as testosterone and estrogen, are not allowed to begin until the child has met the

Keywords: 1189, house, all

Transcript Highlights:

• I haven't changed yet, whether my body produces estrogen or not.
• I haven't changed yet, whether my body produces estrogen or not.
• I haven't changed yet, whether my body produces estrogen or not.
• I haven't changed yet, whether my body produces estrogen or not.
• I haven't changed yet, whether my body produces estrogen or not.

Keywords: 928, house, all

Summary: The House Judiciary Committee opened a hearing on House Bill 148, with the chair limiting testimony to two minutes and asking for no outbursts so the committee could get through eight bills that day. Representative Kofalt, the prime sponsor, said HB 148 was the same as last year’s HB 396, which passed both chambers but was vetoed by the governor. He explained the bill would allow, but not require, separation by biological sex in bathrooms, locker rooms, houses of correction, and certain athletic competitions, leaving local school boards and administrators discretion to set policies. He argued the bill was meant to address safety and privacy concerns and cited a Milford incident and concerns in several school districts as examples of why local flexibility was needed. Committee members questioned the lack of a definition of “biological sex” and how the bill would be applied. Kofalt said he did not think a definition was necessary because males and females are generally understood, and he said the bill would give local policymakers latitude to make practical rules. He also said the bill was intended to address situations where people might misuse transgender claims to access spaces inappropriately. In response to questions, he said he was aware of issues in Kearsarge, Milford, and Mascoma school districts and had heard of discomfort in the State House, though he did not know all the details. Several opponents testified that the bill would discriminate against transgender and non-binary people and create enforcement problems. Executive Councilor Karen Hill said the bill would roll back New Hampshire’s anti-discrimination protections and conflict with the state’s Live Free or Die values. Alice Wade, a trans woman, said she had used women’s restrooms without incident and argued the bill would invite invasive enforcement and harassment. Representative La Selig said the bill was discriminatory and that bathroom concerns were being confused with unrelated harassment by cisgender males. Betsy Harrington supported the bill, citing a girls’ soccer game at Kearsarge that she said was disrupted by a boy playing on a girls’ team. Rosie Emer and her child testified against the bill, saying bathroom restrictions would increase anxiety and risk for trans and non-binary children. Stephen Scaer and Wendy Stallings supported the bill, arguing sex is biologically fixed and that excluding males from female spaces should not require genital inspections. No vote or final committee action was taken in the portion of the hearing provided.

Transcript Highlights:

• In the long term, estrogen is a protective organ, for which there are many, is a protective hormone,
• When people think about ovarian cancer. and hormones like estrogen and progesterone, they often think

Keywords: 988, house, all

Transcript Highlights:

• Estrogen is prescribed to cis girls and women.
• With naturally low estrogen and to treat symptoms of menopause, to prevent osteoporosis, hypoestrogenism

Bills: HB 1239, HB1990, HB1748, HB1749, HB2578, HB2986, HB1970, HB3163, HB2733, HB1922, HB 113, HB 1088, HB1938, HB3004, HB2637, HB2960, HB113

Keywords: public health, access to healthcare, insurance reforms, medical expenses, healthcare providers, mental health, protective custody, preliminary examination, detention period, emergency circumstances, emergency detention, legal framework, detention, healthcare, liability, landowners, nonagricultural land, trespassing, public safety, interpreters

Transcript Highlights:

• testosterone due to pharmacologic interventions blocking puberty in a male and then providing him with estrogen
• :24:41.200> providing<00:24:41.600> him<00:24:41.760> with<00:24:41.919> estrogen
• <00:24:42.320> to and then providing him with estrogen to and then providing him with estrogen

Keywords: 1183, house

Transcript Highlights:

• <02:02:35.400> been People have been trans long before we even knew what testosterone and estrogen
• By the same token, I've been on HRT and estrogen and testosterone blockers for over a year now.
• So, yeah, if you're on testosterone blockers and estrogen, or even just testosterone blockers, I believe
• 48.120> testosterone<02:27:48.640> blockers<02:27:49.160> and<02:27:49.320> estrogen
• , on testosterone blockers and estrogen, on testosterone blockers and estrogen, or<02:27:50.320><

Keywords: 1191, senate, all

Transcript Highlights:

• Perimenopause is the transitional stage before menopause when estrogen levels begin to decrease.
• consecutive months without a menstrual cycle, is the stage when the ovaries stop releasing eggs and estrogen

Bills: SB274, SB301, SB249

Keywords: healthcare, life-sustaining treatment, patient preferences, POLST, advance directive, medical orders, hospital discharge, pregnancy, patient care, discharge planning, healthcare policy, substance use, harm reduction, syringe services, needle exchange, overdose prevention, naloxone, opioid antagonist, drug paraphernalia, syringe

Summary: The committee heard and advanced several measures related to health care, public health, and patient protections. House Concurrent Resolution 148, urging a statewide educational strategy on menopause, was presented as a workplace awareness measure and received supportive comments from members before being released. Senate Bill 274, updating Delaware’s MOST program to POLST and clarifying capacity determinations and documentation for end-of-life orders, also drew supportive testimony from medical and nursing groups and was released. House Bill 458, limiting local backflow preventer requirements for certain low-hazard buildings, was presented as a cost-relief measure for homeowners and small businesses; DHSS expressed concerns but said it was willing to work on amendments and a sunset provision, and the bill was released. Senate Joint Resolution 18, designating August 31, 2026 as International Overdose Awareness Day and ordering flags at half-staff, was released after brief supportive remarks. The committee then considered Senate Bill 339, a technical correction to the advance health care directive form clarifying that an agent’s authority for voluntary mental health admission cannot exceed 72 hours, consistent with existing law. Members asked detailed questions about how the 72-hour limit works and whether it applies to voluntary directives; the sponsor and a Disability Rights Delaware witness explained that the bill only aligns the form with current statute and does not expand authority. The bill was released. House Bill 301, requiring hospitals to create discharge plans for pregnant patients discharged while showing signs of labor, prompted extensive discussion. The sponsor and supporters said it would improve safety, transportation planning, and aftercare, while some members noted Delaware hospitals already do much of this work and questioned whether codifying it was necessary; supporters emphasized maternal mortality disparities and the need for guardrails. The bill was released. Senate Bill 196, creating ownership disclosure requirements for long-term care facilities and resident notice rules after ownership transfers, was presented as a transparency measure for seniors and families and was released after supportive testimony from the Delaware Nurses Association and elder-care advocates. Senate Bill 320, expanding pharmacists’ independent prescriptive authority for certain non-controlled medications and allowing opioid use disorder medications under standing order, with added malpractice reporting requirements in Senate Amendment 2, was supported by pharmacists and nurse practitioners as an access-to-care measure and was released. Senate Substitute 1 for Senate Bill 161, establishing a unified licensing and oversight framework for adult behavioral health providers under DSAM, was presented as a patient-protection measure; providers supported the goal but cautioned that regulations must be workable, and the substitute was released. Senate Joint Resolution 19, directing DHSS to study strategies to reduce health care costs, was released with a note reflecting concerns about broadening the analysis to include additional cost drivers and alternatives. Finally, Senate Bill 249 with Senate Amendment 2, modernizing harm-reduction programs and paraphernalia laws, generated the most extended debate: supporters framed it as life-saving public health policy, while opponents raised concerns about needle litter, community impacts, and whether the approach facilitates addiction. Despite the objections, the bill was released.